Written answers

Wednesday, 20 January 2021

Department of Health

Vaccination Programme

Photo of Neasa HouriganNeasa Hourigan (Dublin Central, Green Party)
Link to this: Individually | In context | Oireachtas source

519. To ask the Minister for Health his plans for persons who are accessing day services and are cared for by home carers over 65 years of age to be vaccinated for Covid-19; the timeline for same; and if he will make a statement on the matter. [2434/21]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

The COVID-19 Vaccine Allocation Strategy sets out a provisional list of groups for vaccination. The Strategy was developed by the National Immunisation Advisory Committee (NIAC) and my Department, endorsed by the National Public Health Emergency Team (NPHET), and approved by Government on 8 December 2020.

Vaccine allocation is a matter for my Department and further information is available here: .

The rollout of the COVID-19 vaccination programme is the responsibility of the HSE.

The aim of the COVID-19 vaccination programme is to ensure, over time, that vaccine will become available to vaccinate all of those for whom the vaccine is indicated. Given that there will be initially limited vaccines available, it will take some time for all to receive those vaccines and that has necessitated an allocation strategy to ensure that those most at risk of death and serious illness receive the vaccine first.

The priority is to first vaccinate and protect directly the most vulnerable amongst us, that is, those most likely to have a poor outcome if they contract the virus. The priority is to directly use vaccines to save lives and reduce serious illness, hence the focus on the over 65 year old cohort in long term residential care facilities, and healthcare workers in frontline services often caring for the most vulnerable.

The next group to be vaccinated are those aged 70 and older and living in the community.

All of the groups will be covered as further vaccine supplies become available and the immunisation programme is rolled out nationally.

The evidence will be kept under review and the allocation groups may be updated, where necessary, in light of new evidence.

The timing of vaccination will be subject to vaccine supply, and the characteristics of the different vaccine products will impact on logistics and the settings in which vaccines can be administered.

Comments

No comments

Log in or join to post a public comment.